FdaApplication
ANDA 217884
Identifiers
- fda_app_no: ANDA217884
Properties
| Property | Value |
|---|---|
| applicant_name | FRESENIUS KABI USA LLC |
| application_type | ANDA |
| approval_date | 2025-02-11 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| SUCCINYLCHOLINE CHLORIDE | SUCCINYLCHOLINE CHLORIDE | 100MG/5ML (20MG/ML) | SOLUTION;INTRAMUSCULAR, INTRAVENOUS |
1 product